Biolife Sciences Inc
OTC:BLFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Investment Trust of India Ltd
NSE:THEINVEST
|
IN |
|
I
|
International Housewares Retail Co Ltd
HKEX:1373
|
HK |
|
Zensar Technologies Ltd
NSE:ZENSARTECH
|
IN |
|
Delivery Hero SE
XETRA:DHER
|
DE |
|
Jamieson Wellness Inc
TSX:JWEL
|
CA |
|
G
|
Great Wall Terroir Holdings Ltd
HKEX:524
|
HK |
|
Riken Corundum Co Ltd
TSE:5395
|
JP |
|
O
|
OpenWork Inc
TSE:5139
|
JP |
|
S
|
Sharda Motor Industries Ltd
BSE:535602
|
IN |
|
China Aluminum Cans Holdings Ltd
HKEX:6898
|
CN |
|
EGL Holdings Co Ltd
HKEX:6882
|
HK |
|
M
|
Million Hope Industries Holdings Ltd
HKEX:1897
|
HK |
|
H
|
Hunan Copote Science Technology Co Ltd
SSE:600476
|
CN |
|
T
|
Tempus Holdings Ltd
HKEX:6880
|
HK |
Biolife Sciences Inc
Total Equity
Biolife Sciences Inc
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Biolife Sciences Inc
OTC:BLFE
|
Total Equity
-$880.3k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Total Equity
$24.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
14%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Total Equity
$10.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
15%
|
|
|
Stryker Corp
NYSE:SYK
|
Total Equity
$22.4B
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Total Equity
$52.1B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Total Equity
$17.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Biolife Sciences Inc
Glance View
Bio Life Sciences, Inc. engages in the development of mobile applications and Voice over Internet Protocol (VoIP) services. The company is headquartered in New York City, New York. The company went IPO on 2005-04-25. The Company’s core business develops, licenses and distributes antimicrobial products, non-contract human temperature screening technology and touchless vending products. Its technology solutions include Antimicrobial Copper Air Filters, Non-contact Human Temperature Screening, Ultraviolet Sterilization, and Next-Generation Vending Machines. Its BioLife Antimicrobial Copper Air Cleaner fabric filters capture and kill bacteria that passes through air vents and releases clean air along with deposits of copper ions. BioLife Intelligent Touchless Vending and Marketplaces that provides digital advertising and digital vending machines serving a range of personal protective equipment and antimicrobial products. Its non-contract human temperature screening technology solutions detect subjects’ body temperature.
See Also
What is Biolife Sciences Inc's Total Equity?
Total Equity
-880.3k
USD
Based on the financial report for Nov 30, 2021, Biolife Sciences Inc's Total Equity amounts to -880.3k USD.
What is Biolife Sciences Inc's Total Equity growth rate?
Total Equity CAGR 1Y
-28%
Over the last year, the Total Equity growth was -28%.